|
Atomistry » Fluorine » PDB 4hxn-4ijh » 4i22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4hxn-4ijh » 4i22 » |
Fluorine in PDB 4i22: Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with GefitinibEnzymatic activity of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
All present enzymatic activity of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib:
2.7.10.1; Protein crystallography data
The structure of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib, PDB code: 4i22
was solved by
K.S.Gajiwala,
J.Feng,
R.Ferre,
K.Ryan,
O.Brodsky,
A.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4i22:
The structure of Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
(pdb code 4i22). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib, PDB code: 4i22: Fluorine binding site 1 out of 1 in 4i22Go back to![]() ![]()
Fluorine binding site 1 out
of 1 in the Structure of the Monomeric (V948R)Gefitinib/Erlotinib Resistant Double Mutant (L858R+T790M) Egfr Kinase Domain Co-Crystallized with Gefitinib
![]() Mono view ![]() Stereo pair view
Reference:
K.S.Gajiwala,
J.Feng,
R.Ferre,
K.Ryan,
O.Brodsky,
S.Weinrich,
J.C.Kath,
A.Stewart.
Insights Into the Aberrant Activity of Mutant Egfr Kinase Domain and Drug Recognition. Structure V. 21 209 2013.
Page generated: Thu Aug 1 02:14:12 2024
ISSN: ISSN 0969-2126 PubMed: 23273428 DOI: 10.1016/J.STR.2012.11.014 |
Last articlesZn in 9J0NZn in 9J0O Zn in 9J0P Zn in 9FJX Zn in 9EKB Zn in 9C0F Zn in 9CAH Zn in 9CH0 Zn in 9CH3 Zn in 9CH1 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |